-
1
-
-
1242340431
-
Oncogenic Ras and its role in tumor cell invasion and metastasis
-
Campbell PM and Der CJ. Oncogenic Ras and its role in tumor cell invasion and metastasis. Seminars in cancer biology. 2004; 14(2):105-114.
-
(2004)
Seminars in cancer biology.
, vol.14
, Issue.2
, pp. 105-114
-
-
Campbell, P.M.1
Der, C.J.2
-
3
-
-
84862571677
-
Prognostic and predictive value of K-RAS mutations in non-small cell lung cancer
-
Califano R, Landi L and Cappuzzo F. Prognostic and predictive value of K-RAS mutations in non-small cell lung cancer. Drugs. 2012; 72 Suppl 1:28-36.
-
(2012)
Drugs
, vol.72
, Issue.SUPPL. 1
, pp. 28-36
-
-
Califano, R.1
Landi, L.2
Cappuzzo, F.3
-
4
-
-
78650026316
-
KRAS and BRAF: drug targets and predictive biomarkers
-
Vakiani E and Solit DB. KRAS and BRAF: drug targets and predictive biomarkers. The Journal of pathology. 2011; 223(2):219-229.
-
(2011)
The Journal of pathology.
, vol.223
, Issue.2
, pp. 219-229
-
-
Vakiani, E.1
Solit, D.B.2
-
5
-
-
77956268839
-
Understanding resistance to EGFR inhibitors-impact on future treatment strategies
-
Wheeler DL, Dunn EF and Harari PM. Understanding resistance to EGFR inhibitors-impact on future treatment strategies. Nature reviews Clinical oncology. 2010; 7(9):493-507.
-
(2010)
Nature reviews Clinical oncology.
, vol.7
, Issue.9
, pp. 493-507
-
-
Wheeler, D.L.1
Dunn, E.F.2
Harari, P.M.3
-
7
-
-
33750370444
-
MicroRNA signatures in human cancers
-
Calin GA and Croce CM. MicroRNA signatures in human cancers. Nature reviews Cancer. 2006; 6(11):857-866.
-
(2006)
Nature reviews Cancer.
, vol.6
, Issue.11
, pp. 857-866
-
-
Calin, G.A.1
Croce, C.M.2
-
9
-
-
33749507943
-
A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes
-
Kent OA and Mendell JT. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene. 2006; 25(46):6188-6196.
-
(2006)
Oncogene.
, vol.25
, Issue.46
, pp. 6188-6196
-
-
Kent, O.A.1
Mendell, J.T.2
-
10
-
-
20044395613
-
RAS is regulated by the let-7 microRNA family
-
Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D and Slack FJ. RAS is regulated by the let-7 microRNA family. Cell. 2005; 120(5):635-647.
-
(2005)
Cell.
, vol.120
, Issue.5
, pp. 635-647
-
-
Johnson, S.M.1
Grosshans, H.2
Shingara, J.3
Byrom, M.4
Jarvis, R.5
Cheng, A.6
Labourier, E.7
Reinert, K.L.8
Brown, D.9
Slack, F.J.10
-
11
-
-
42049103216
-
The let-7 microRNA reduces tumor growth in mouse models of lung cancer
-
Esquela-Kerscher A, Trang P, Wiggins JF, Patrawala L, Cheng A, Ford L, Weidhaas JB, Brown D, Bader AG and Slack FJ. The let-7 microRNA reduces tumor growth in mouse models of lung cancer. Cell cycle. 2008; 7(6):759-764.
-
(2008)
Cell cycle.
, vol.7
, Issue.6
, pp. 759-764
-
-
Esquela-Kerscher, A.1
Trang, P.2
Wiggins, J.F.3
Patrawala, L.4
Cheng, A.5
Ford, L.6
Weidhaas, J.B.7
Brown, D.8
Bader, A.G.9
Slack, F.J.10
-
12
-
-
34548012848
-
The let-7 microRNA represses cell proliferation pathways in human cells
-
Johnson CD, Esquela-Kerscher A, Stefani G, Byrom M, Kelnar K, Ovcharenko D, Wilson M, Wang X, Shelton J, Shingara J, Chin L, Brown D and Slack FJ. The let-7 microRNA represses cell proliferation pathways in human cells. Cancer research. 2007; 67(16):7713-7722.
-
(2007)
Cancer research.
, vol.67
, Issue.16
, pp. 7713-7722
-
-
Johnson, C.D.1
Esquela-Kerscher, A.2
Stefani, G.3
Byrom, M.4
Kelnar, K.5
Ovcharenko, D.6
Wilson, M.7
Wang, X.8
Shelton, J.9
Shingara, J.10
Chin, L.11
Brown, D.12
Slack, F.J.13
-
13
-
-
41649114199
-
Suppression of non-small cell lung tumor development by the let-7 microRNA family
-
Kumar MS, Erkeland SJ, Pester RE, Chen CY, Ebert MS, Sharp PA and Jacks T. Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proceedings of the National Academy of Sciences of the United States of America. 2008; 105(10):3903-3908.
-
(2008)
Proceedings of the National Academy of Sciences of the United States of America.
, vol.105
, Issue.10
, pp. 3903-3908
-
-
Kumar, M.S.1
Erkeland, S.J.2
Pester, R.E.3
Chen, C.Y.4
Ebert, M.S.5
Sharp, P.A.6
Jacks, T.7
-
14
-
-
62249137047
-
Role of miR-143 targeting KRAS in colorectal tumorigenesis
-
Chen X, Guo X, Zhang H, Xiang Y, Chen J, Yin Y, Cai X, Wang K, Wang G, Ba Y, Zhu L, Wang J, Yang R, Zhang Y, Ren Z, Zen K, et al. Role of miR-143 targeting KRAS in colorectal tumorigenesis. Oncogene. 2009; 28(10):1385-1392.
-
(2009)
Oncogene.
, vol.28
, Issue.10
, pp. 1385-1392
-
-
Chen, X.1
Guo, X.2
Zhang, H.3
Xiang, Y.4
Chen, J.5
Yin, Y.6
Cai, X.7
Wang, K.8
Wang, G.9
Ba, Y.10
Zhu, L.11
Wang, J.12
Yang, R.13
Zhang, Y.14
Ren, Z.15
Zen, K.16
-
15
-
-
79953696225
-
miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS
-
Xu B, Niu X, Zhang X, Tao J, Wu D, Wang Z, Li P, Zhang W, Wu H, Feng N, Wang Z, Hua L and Wang X. miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS. Molecular and cellular biochemistry. 2011; 350(1-2):207-213.
-
(2011)
Molecular and cellular biochemistry
, vol.350
, Issue.1-2
, pp. 207-213
-
-
Xu, B.1
Niu, X.2
Zhang, X.3
Tao, J.4
Wu, D.5
Wang, Z.6
Li, P.7
Zhang, W.8
Wu, H.9
Feng, N.10
Wang, Z.11
Hua, L.12
Wang, X.13
-
17
-
-
84862219230
-
Deregulated miRNAs in hereditary breast cancer revealed a role for miR-30c in regulating KRAS oncogene
-
Tanic M, Yanowsky K, Rodriguez-Antona C, Andres R, Marquez-Rodas I, Osorio A, Benitez J and Martinez-Delgado B. Deregulated miRNAs in hereditary breast cancer revealed a role for miR-30c in regulating KRAS oncogene. PloS one. 2012; 7(6):e38847.
-
(2012)
PloS one.
, vol.7
, Issue.6
-
-
Tanic, M.1
Yanowsky, K.2
Rodriguez-Antona, C.3
Andres, R.4
Marquez-Rodas, I.5
Osorio, A.6
Benitez, J.7
Martinez-Delgado, B.8
-
18
-
-
43049103824
-
The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
-
Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y and Goodall GJ. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nature cell biology. 2008; 10(5):593-601.
-
(2008)
Nature cell biology.
, vol.10
, Issue.5
, pp. 593-601
-
-
Gregory, P.A.1
Bert, A.G.2
Paterson, E.L.3
Barry, S.C.4
Tsykin, A.5
Farshid, G.6
Vadas, M.A.7
Khew-Goodall, Y.8
Goodall, G.J.9
-
19
-
-
34548565806
-
Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin
-
Hurteau GJ, Carlson JA, Spivack SD and Brock GJ. Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. Cancer research. 2007; 67(17):7972-7976.
-
(2007)
Cancer research.
, vol.67
, Issue.17
, pp. 7972-7976
-
-
Hurteau, G.J.1
Carlson, J.A.2
Spivack, S.D.3
Brock, G.J.4
-
20
-
-
47249091921
-
The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2
-
Korpal M, Lee ES, Hu G and Kang Y. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. The Journal of biological chemistry. 2008; 283(22):14910-14914.
-
(2008)
The Journal of biological chemistry.
, vol.283
, Issue.22
, pp. 14910-14914
-
-
Korpal, M.1
Lee, E.S.2
Hu, G.3
Kang, Y.4
-
21
-
-
44649163918
-
A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells
-
Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna S and Brabletz T. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO reports. 2008; 9(6):582-589.
-
(2008)
EMBO reports.
, vol.9
, Issue.6
, pp. 582-589
-
-
Burk, U.1
Schubert, J.2
Wellner, U.3
Schmalhofer, O.4
Vincan, E.5
Spaderna, S.6
Brabletz, T.7
-
22
-
-
70349142665
-
Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression
-
Gibbons DL, Lin W, Creighton CJ, Rizvi ZH, Gregory PA, Goodall GJ, Thilaganathan N, Du L, Zhang Y, Pertsemlidis A and Kurie JM. Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression. Genes&development. 2009; 23(18):2140-2151.
-
(2009)
Genes&development.
, vol.23
, Issue.18
, pp. 2140-2151
-
-
Gibbons, D.L.1
Lin, W.2
Creighton, C.J.3
Rizvi, Z.H.4
Gregory, P.A.5
Goodall, G.J.6
Thilaganathan, N.7
Du, L.8
Zhang, Y.9
Pertsemlidis, A.10
Kurie, J.M.11
-
23
-
-
79955102595
-
Targets of miR-200c mediate suppression of cell motility and anoikis resistance
-
Howe EN, Cochrane DR and Richer JK. Targets of miR-200c mediate suppression of cell motility and anoikis resistance. Breast cancer research: BCR. 2011; 13(2):R45.
-
(2011)
Breast cancer research: BCR.
, vol.13
, Issue.2
-
-
Howe, E.N.1
Cochrane, D.R.2
Richer, J.K.3
-
24
-
-
84863012099
-
MicroRNA-200c represses migration and invasion of breast cancer cells by targeting actin-regulatory proteins FHOD1 and PPM1F
-
Jurmeister S, Baumann M, Balwierz A, Keklikoglou I, Ward A, Uhlmann S, Zhang JD, Wiemann S and Sahin O. MicroRNA-200c represses migration and invasion of breast cancer cells by targeting actin-regulatory proteins FHOD1 and PPM1F. Molecular and cellular biology. 2012; 32(3):633-651.
-
(2012)
Molecular and cellular biology.
, vol.32
, Issue.3
, pp. 633-651
-
-
Jurmeister, S.1
Baumann, M.2
Balwierz, A.3
Keklikoglou, I.4
Ward, A.5
Uhlmann, S.6
Zhang, J.D.7
Wiemann, S.8
Sahin, O.9
-
25
-
-
70349145414
-
MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer
-
Olson P, Lu J, Zhang H, Shai A, Chun MG, Wang Y, Libutti SK, Nakakura EK, Golub TR and Hanahan D. MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer. Genes&development. 2009; 23(18):2152-2165.
-
(2009)
Genes&development.
, vol.23
, Issue.18
, pp. 2152-2165
-
-
Olson, P.1
Lu, J.2
Zhang, H.3
Shai, A.4
Chun, M.G.5
Wang, Y.6
Libutti, S.K.7
Nakakura, E.K.8
Golub, T.R.9
Hanahan, D.10
-
26
-
-
77956547097
-
Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells
-
Iliopoulos D, Lindahl-Allen M, Polytarchou C, Hirsch HA, Tsichlis PN and Struhl K. Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells. Molecular cell. 2010; 39(5):761-772.
-
(2010)
Molecular cell.
, vol.39
, Issue.5
, pp. 761-772
-
-
Iliopoulos, D.1
Lindahl-Allen, M.2
Polytarchou, C.3
Hirsch, H.A.4
Tsichlis, P.N.5
Struhl, K.6
-
27
-
-
68049114782
-
Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells
-
Shimono Y, Zabala M, Cho RW, Lobo N, Dalerba P, Qian D, Diehn M, Liu H, Panula SP, Chiao E, Dirbas FM, Somlo G, Pera RA, Lao K and Clarke MF. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell. 2009; 138(3):592-603.
-
(2009)
Cell.
, vol.138
, Issue.3
, pp. 592-603
-
-
Shimono, Y.1
Zabala, M.2
Cho, R.W.3
Lobo, N.4
Dalerba, P.5
Qian, D.6
Diehn, M.7
Liu, H.8
Panula, S.P.9
Chiao, E.10
Dirbas, F.M.11
Somlo, G.12
Pera, R.A.13
Lao, K.14
Clarke, M.F.15
-
28
-
-
69349087756
-
miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy
-
Adam L, Zhong M, Choi W, Qi W, Nicoloso M, Arora A, Calin G, Wang H, Siefker-Radtke A, McConkey D, Bar-Eli M and Dinney C. miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy. Clinical cancer research: an official journal of the American Association for Cancer Research. 2009; 15(16):5060-5072.
-
(2009)
Clinical cancer research: an official journal of the American Association for Cancer Research
, vol.15
, Issue.16
, pp. 5060-5072
-
-
Adam, L.1
Zhong, M.2
Choi, W.3
Qi, W.4
Nicoloso, M.5
Arora, A.6
Calin, G.7
Wang, H.8
Siefker-Radtke, A.9
McConkey, D.10
Bar-Eli, M.11
Dinney, C.12
-
29
-
-
84855359334
-
A microRNA gene expression signature predicts response to erlotinib in epithelial cancer cell lines and targets EMT
-
Bryant JL, Britson J, Balko JM, Willian M, Timmons R, Frolov A and Black EP. A microRNA gene expression signature predicts response to erlotinib in epithelial cancer cell lines and targets EMT. British journal of cancer. 2012; 106(1):148-156.
-
(2012)
British journal of cancer.
, vol.106
, Issue.1
, pp. 148-156
-
-
Bryant, J.L.1
Britson, J.2
Balko, J.M.3
Willian, M.4
Timmons, R.5
Frolov, A.6
Black, E.P.7
-
30
-
-
77954863985
-
Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers
-
Cochrane DR, Howe EN, Spoelstra NS and Richer JK. Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers. Journal of oncology. 2010; 2010:821717.
-
(2010)
Journal of oncology.
, vol.2010
, pp. 821717
-
-
Cochrane, D.R.1
Howe, E.N.2
Spoelstra, N.S.3
Richer, J.K.4
-
31
-
-
66849140943
-
MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents
-
Cochrane DR, Spoelstra NS, Howe EN, Nordeen SK and Richer JK. MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents. Molecular cancer therapeutics. 2009; 8(5):1055-1066.
-
(2009)
Molecular cancer therapeutics.
, vol.8
, Issue.5
, pp. 1055-1066
-
-
Cochrane, D.R.1
Spoelstra, N.S.2
Howe, E.N.3
Nordeen, S.K.4
Richer, J.K.5
-
32
-
-
84870549360
-
miR-200c sensitizes breast cancer cells to doxorubicin treatment by decreasing TrkB and Bmi1 expression
-
Kopp F, Oak PS, Wagner E and Roidl A. miR-200c sensitizes breast cancer cells to doxorubicin treatment by decreasing TrkB and Bmi1 expression. PloS one. 2012; 7(11):e50469.
-
(2012)
PloS one
, vol.7
, Issue.11
-
-
Kopp, F.1
Oak, P.S.2
Wagner, E.3
Roidl, A.4
-
33
-
-
77951248184
-
E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells
-
Tryndyak VP, Beland FA and Pogribny IP. E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells. International journal of cancer Journal international du cancer. 2010; 126(11):2575-2583.
-
(2010)
International journal of cancer Journal international du cancer.
, vol.126
, Issue.11
, pp. 2575-2583
-
-
Tryndyak, V.P.1
Beland, F.A.2
Pogribny, I.P.3
-
34
-
-
0346094457
-
Prediction of mammalian microRNA targets
-
Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP and Burge CB. Prediction of mammalian microRNA targets. Cell. 2003; 115(7):787-798.
-
(2003)
Cell.
, vol.115
, Issue.7
, pp. 787-798
-
-
Lewis, B.P.1
Shih, I.H.2
Jones-Rhoades, M.W.3
Bartel, D.P.4
Burge, C.B.5
-
35
-
-
14044251458
-
Human MicroRNA targets
-
John B, Enright AJ, Aravin A, Tuschl T, Sander C and Marks DS. Human MicroRNA targets. PLoS biology. 2004; 2(11):e363.
-
(2004)
PLoS biology.
, vol.2
, Issue.11
-
-
John, B.1
Enright, A.J.2
Aravin, A.3
Tuschl, T.4
Sander, C.5
Marks, D.S.6
-
36
-
-
70449372292
-
Accurate microRNA target prediction correlates with protein repression levels
-
Maragkakis M, Alexiou P, Papadopoulos GL, Reczko M, Dalamagas T, Giannopoulos G, Goumas G, Koukis E, Kourtis K, Simossis VA, Sethupathy P, Vergoulis T, Koziris N, Sellis T, Tsanakas P and Hatzigeorgiou AG. Accurate microRNA target prediction correlates with protein repression levels. BMC bioinformatics. 2009; 10:295.
-
(2009)
BMC bioinformatics.
, vol.10
, pp. 295
-
-
Maragkakis, M.1
Alexiou, P.2
Papadopoulos, G.L.3
Reczko, M.4
Dalamagas, T.5
Giannopoulos, G.6
Goumas, G.7
Koukis, E.8
Kourtis, K.9
Simossis, V.A.10
Sethupathy, P.11
Vergoulis, T.12
Koziris, N.13
Sellis, T.14
Tsanakas, P.15
Hatzigeorgiou, A.G.16
-
37
-
-
67650747402
-
DIANA-microT web server: elucidating microRNA functions through target prediction
-
Maragkakis M, Reczko M, Simossis VA, Alexiou P, Papadopoulos GL, Dalamagas T, Giannopoulos G, Goumas G, Koukis E, Kourtis K, Vergoulis T, Koziris N, Sellis T, Tsanakas P and Hatzigeorgiou AG. DIANA-microT web server: elucidating microRNA functions through target prediction. Nucleic acids research. 2009; 37(Web Server issue):W273-276.
-
(2009)
Nucleic acids research
, vol.37
, Issue.WEB SERVER ISSUE
-
-
Maragkakis, M.1
Reczko, M.2
Simossis, V.A.3
Alexiou, P.4
Papadopoulos, G.L.5
Dalamagas, T.6
Giannopoulos, G.7
Goumas, G.8
Koukis, E.9
Kourtis, K.10
Vergoulis, T.11
Koziris, N.12
Sellis, T.13
Tsanakas, P.14
Hatzigeorgiou, A.G.15
-
38
-
-
13944282215
-
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs
-
Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS and Johnson JM. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature. 2005; 433(7027):769-773.
-
(2005)
Nature.
, vol.433
, Issue.7027
, pp. 769-773
-
-
Lim, L.P.1
Lau, N.C.2
Garrett-Engele, P.3
Grimson, A.4
Schelter, J.M.5
Castle, J.6
Bartel, D.P.7
Linsley, P.S.8
Johnson, J.M.9
-
39
-
-
33947230755
-
Phosphatidylinositol-3-OH kinase or RAS pathway mutations in human breast cancer cell lines
-
Hollestelle A, Elstrodt F, Nagel JH, Kallemeijn WW and Schutte M. Phosphatidylinositol-3-OH kinase or RAS pathway mutations in human breast cancer cell lines. Molecular cancer research: MCR. 2007; 5(2):195-201.
-
(2007)
Molecular cancer research: MCR.
, vol.5
, Issue.2
, pp. 195-201
-
-
Hollestelle, A.1
Elstrodt, F.2
Nagel, J.H.3
Kallemeijn, W.W.4
Schutte, M.5
-
40
-
-
0023651180
-
The human c-Kirsten ras gene is activated by a novel mutation in codon 13 in the breast carcinoma cell line MDA-MB231
-
Kozma SC, Bogaard ME, Buser K, Saurer SM, Bos JL, Groner B and Hynes NE. The human c-Kirsten ras gene is activated by a novel mutation in codon 13 in the breast carcinoma cell line MDA-MB231. Nucleic acids research. 1987; 15(15):5963-5971.
-
(1987)
Nucleic acids research.
, vol.15
, Issue.15
, pp. 5963-5971
-
-
Kozma, S.C.1
Bogaard, M.E.2
Buser, K.3
Saurer, S.M.4
Bos, J.L.5
Groner, B.6
Hynes, N.E.7
-
41
-
-
79951823579
-
Knockdown of oncogenic KRAS in non-small cell lung cancers suppresses tumor growth and sensitizes tumor cells to targeted therapy
-
Sunaga N, Shames DS, Girard L, Peyton M, Larsen JE, Imai H, Soh J, Sato M, Yanagitani N, Kaira K, Xie Y, Gazdar AF, Mori M and Minna JD. Knockdown of oncogenic KRAS in non-small cell lung cancers suppresses tumor growth and sensitizes tumor cells to targeted therapy. Molecular cancer therapeutics. 2011; 10(2):336-346.
-
(2011)
Molecular cancer therapeutics.
, vol.10
, Issue.2
, pp. 336-346
-
-
Sunaga, N.1
Shames, D.S.2
Girard, L.3
Peyton, M.4
Larsen, J.E.5
Imai, H.6
Soh, J.7
Sato, M.8
Yanagitani, N.9
Kaira, K.10
Xie, Y.11
Gazdar, A.F.12
Mori, M.13
Minna, J.D.14
-
42
-
-
11144356354
-
Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects
-
Tuveson DA, Shaw AT, Willis NA, Silver DP, Jackson EL, Chang S, Mercer KL, Grochow R, Hock H, Crowley D, Hingorani SR, Zaks T, King C, Jacobetz MA, Wang L, Bronson RT, et al. Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. Cancer cell. 2004; 5(4):375-387.
-
(2004)
Cancer cell.
, vol.5
, Issue.4
, pp. 375-387
-
-
Tuveson, D.A.1
Shaw, A.T.2
Willis, N.A.3
Silver, D.P.4
Jackson, E.L.5
Chang, S.6
Mercer, K.L.7
Grochow, R.8
Hock, H.9
Crowley, D.10
Hingorani, S.R.11
Zaks, T.12
King, C.13
Jacobetz, M.A.14
Wang, L.15
Bronson, R.T.16
-
43
-
-
64049102720
-
Oncogenic K-Ras regulates proliferation and cell junctions in lung epithelial cells through induction of cyclooxygenase-2 and activation of metalloproteinase-9
-
Wang XQ, Li H, Van Putten V, Winn RA, Heasley LE and Nemenoff RA. Oncogenic K-Ras regulates proliferation and cell junctions in lung epithelial cells through induction of cyclooxygenase-2 and activation of metalloproteinase-9. Molecular biology of the cell. 2009; 20(3):791-800.
-
(2009)
Molecular biology of the cell.
, vol.20
, Issue.3
, pp. 791-800
-
-
Wang, X.Q.1
Li, H.2
Van Putten, V.3
Winn, R.A.4
Heasley, L.E.5
Nemenoff, R.A.6
-
44
-
-
4143146567
-
Oncogenic K-ras drives cell cycle progression and phenotypic conversion of primary pancreatic duct epithelial cells
-
Agbunag C and Bar-Sagi D. Oncogenic K-ras drives cell cycle progression and phenotypic conversion of primary pancreatic duct epithelial cells. Cancer research. 2004; 64(16):5659-5663.
-
(2004)
Cancer research.
, vol.64
, Issue.16
, pp. 5659-5663
-
-
Agbunag, C.1
Bar-Sagi, D.2
-
45
-
-
0030996978
-
K-ras modulates the cell cycle via both positive and negative regulatory pathways
-
Fan J and Bertino JR. K-ras modulates the cell cycle via both positive and negative regulatory pathways. Oncogene. 1997; 14(21):2595-2607.
-
(1997)
Oncogene.
, vol.14
, Issue.21
, pp. 2595-2607
-
-
Fan, J.1
Bertino, J.R.2
-
46
-
-
0020624455
-
Structure of the Ki-ras gene of the human lung carcinoma cell line Calu-1
-
Shimizu K, Birnbaum D, Ruley MA, Fasano O, Suard Y, Edlund L, Taparowsky E, Goldfarb M and Wigler M. Structure of the Ki-ras gene of the human lung carcinoma cell line Calu-1. Nature. 1983; 304(5926):497-500.
-
(1983)
Nature.
, vol.304
, Issue.5926
, pp. 497-500
-
-
Shimizu, K.1
Birnbaum, D.2
Ruley, M.A.3
Fasano, O.4
Suard, Y.5
Edlund, L.6
Taparowsky, E.7
Goldfarb, M.8
Wigler, M.9
-
47
-
-
0022622668
-
Four human carcinoma cell lines with novel mutations in position 12 of c-K-ras oncogene
-
Valenzuela DM and Groffen J. Four human carcinoma cell lines with novel mutations in position 12 of c-K-ras oncogene. Nucleic acids research. 1986; 14(2):843-852.
-
(1986)
Nucleic acids research.
, vol.14
, Issue.2
, pp. 843-852
-
-
Valenzuela, D.M.1
Groffen, J.2
-
48
-
-
52449092107
-
Breast tumor cells with PI3K mutation or HER2 amplification are selectively addicted to Akt signaling
-
She QB, Chandarlapaty S, Ye Q, Lobo J, Haskell KM, Leander KR, DeFeo-Jones D, Huber HE and Rosen N. Breast tumor cells with PI3K mutation or HER2 amplification are selectively addicted to Akt signaling. PloS one. 2008; 3(8):e3065.
-
(2008)
PloS one.
, vol.3
, Issue.8
-
-
She, Q.B.1
Chandarlapaty, S.2
Ye, Q.3
Lobo, J.4
Haskell, K.M.5
Leander, K.R.6
DeFeo-Jones, D.7
Huber, H.E.8
Rosen, N.9
-
49
-
-
77955172153
-
miR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer
-
Uhlmann S, Zhang JD, Schwager A, Mannsperger H, Riazalhosseini Y, Burmester S, Ward A, Korf U, Wiemann S and Sahin O. miR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer. Oncogene. 2010; 29(30):4297-4306.
-
(2010)
Oncogene
, vol.29
, Issue.30
, pp. 4297-4306
-
-
Uhlmann, S.1
Zhang, J.D.2
Schwager, A.3
Mannsperger, H.4
Riazalhosseini, Y.5
Burmester, S.6
Ward, A.7
Korf, U.8
Wiemann, S.9
Sahin, O.10
-
50
-
-
1342289563
-
Bmi1, stem cells, and senescence regulation
-
Park IK, Morrison SJ and Clarke MF. Bmi1, stem cells, and senescence regulation. The Journal of clinical investigation. 2004; 113(2):175-179.
-
(2004)
The Journal of clinical investigation.
, vol.113
, Issue.2
, pp. 175-179
-
-
Park, I.K.1
Morrison, S.J.2
Clarke, M.F.3
-
51
-
-
84860214990
-
Intra-tumour heterogeneity: a looking glass for cancer?
-
Marusyk A, Almendro V and Polyak K. Intra-tumour heterogeneity: a looking glass for cancer? Nature reviews Cancer. 2012; 12(5):323-334.
-
(2012)
Nature reviews Cancer.
, vol.12
, Issue.5
, pp. 323-334
-
-
Marusyk, A.1
Almendro, V.2
Polyak, K.3
-
52
-
-
84864812339
-
Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives
-
Saunders NA, Simpson F, Thompson EW, Hill MM, Endo-Munoz L, Leggatt G, Minchin RF and Guminski A. Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives. EMBO molecular medicine. 2012; 4(8):675-684.
-
(2012)
EMBO molecular medicine.
, vol.4
, Issue.8
, pp. 675-684
-
-
Saunders, N.A.1
Simpson, F.2
Thompson, E.W.3
Hill, M.M.4
Endo-Munoz, L.5
Leggatt, G.6
Minchin, R.F.7
Guminski, A.8
-
54
-
-
71249151558
-
Hydrophobically modified oligoethylenimines as highly efficient transfection agents for siRNA delivery
-
Philipp A, Zhao X, Tarcha P, Wagner E and Zintchenko A. Hydrophobically modified oligoethylenimines as highly efficient transfection agents for siRNA delivery. Bioconjugate chemistry. 2009; 20(11):2055-2061.
-
(2009)
Bioconjugate chemistry.
, vol.20
, Issue.11
, pp. 2055-2061
-
-
Philipp, A.1
Zhao, X.2
Tarcha, P.3
Wagner, E.4
Zintchenko, A.5
-
55
-
-
0041935939
-
ImageJ
-
U.S. National Institutes of Health, Bethesda, Maryland, USA
-
Rasband WS. (1997-2008). ImageJ, U.S. National Institutes of Health, Bethesda, Maryland, USA.
-
(1997)
-
-
Rasband, W.S.1
-
56
-
-
54249117763
-
A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk
-
Chin LJ, Ratner E, Leng S, Zhai R, Nallur S, Babar I, Muller RU, Straka E, Su L, Burki EA, Crowell RE, Patel R, Kulkarni T, Homer R, Zelterman D, Kidd KK, et al. A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk. Cancer research. 2008; 68(20):8535-8540
-
(2008)
Cancer research.
, vol.68
, Issue.20
, pp. 8535-8540
-
-
Chin, L.J.1
Ratner, E.2
Leng, S.3
Zhai, R.4
Nallur, S.5
Babar, I.6
Muller, R.U.7
Straka, E.8
Su, L.9
Burki, E.A.10
Crowell, R.E.11
Patel, R.12
Kulkarni, T.13
Homer, R.14
Zelterman, D.15
Kidd, K.K.16
|